JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB5416

Anti-Influenza A Virus M2 Protein antibody [14C2]

5

(2 Reviews)

|

(81 Publications)

Mouse Monoclonal M2 antibody. Suitable for ICC and reacts with Influenza A samples. Cited in 81 publications.
6 Images
Immunocytochemistry - Anti-Influenza A Virus M2 Protein antibody [14C2] (AB5416)
  • ICC

Unknown

Immunocytochemistry - Anti-Influenza A Virus M2 Protein antibody [14C2] (AB5416)

Immunofluorescence staining of infected dog MDCK cells using ab5416.

Western blot - Anti-Influenza A Virus M2 Protein antibody [14C2] (AB5416)
  • WB

CiteAb

Western blot - Anti-Influenza A Virus M2 Protein antibody [14C2] (AB5416)

Western Blotting using Anti-Influenza A Virus M2 Protein antibody [14C2], ab5416. Publication image from Moriyama, M. et al., 2019, Nat Commun, 31604929. Legend direct from paper.

Influenza virus stimulates DDX41-dependent IFN-β gene expression. a cGAS-293FT cells transfected with siRNA targeting DDX41 or control siRNA were infected with influenza virus for 24 h. Cell lysates were collected and blotted using the indicated antibodies (left panel). IFN-β mRNA levels were assessed by quantitative PCR with β-actin as an internal control (right panel). b, c cGAS-293FT cells were infected with WT (left panel) or δNS1 influenza virus (right panel) for 24 h in the presence or absence of LFM-A13 (100 µM) (b). WT or DDX41-deficient STING-A549 cells were infected with PR8 (left panel), or EMCV (right panel) for 24 h (c). IFN-β mRNA levels were assessed by quantitative PCR with β-actin as an internal control. d Pure cytosolic fraction prepared from digitonin extracts of mock- or δNS1 influenza virus-infected cGAS-293FT cells were treated with DNase I or RNase H. Cytosolic mtDNA was assessed by quantitative PCR. e HEK293FT cells were transfected with DNA extracted from DNase I- or RNase H-treated pure cytosolic fraction for 24 h. IFN-β mRNA levels were assessed by quantitative PCR with β-actin as an internal control. f STING-A549 cells transfected with siRNA targeting DDX41 or control siRNA were infected with PR8 virus for 24 h. Cell lysates were collected at 24 h post infection and blotted using the indicated antibodies (left panel). Pure cytosolic extracts were collected at 24 h post infection and analyzed for cGAMP by ELISA (right panel). g, h HEK293FT cells were transfected with siRNA targeting DDX41. Two days later, cells were transfected with the expression plasmid encoding Flag-tagged DDX41 or DDX41 (Y414F) mutant. Twenty-four hours after DNA transfection, the cells were infected with WT (g) δNS1 influenza virus (h) for 24 h. Cell lysates were collected at 24 h post infection and blotted using the indicated antibodies (left panel). IFN-β mRNA levels were assessed by quantitative PCR with β-actin as an internal control (right panel). These data are from three independent experiments (mean ± s.e.m.). **P < 0.01, ***P < 0.001; n.s., not significant (one-way ANOVA and Tukey’s test). Source data are provided as a Source Data file

false

Western blot - Anti-Influenza A Virus M2 Protein antibody [14C2] (AB5416)
  • WB

CiteAb

Western blot - Anti-Influenza A Virus M2 Protein antibody [14C2] (AB5416)

Western Blotting using Anti-Influenza A Virus M2 Protein antibody [14C2], ab5416. Publication image from Moriyama, M. et al., 2019, Nat Commun, 31604929. Legend direct from paper.

Influenza virus NS1 protein associates with mtDNA. a HEK293FT cells were transfected with the expression plasmid encoding EGFP, Flag-tagged M2, NS1, or NS138/41 mutant. Twenty-four hours after transfection, the cells were infected with δNS1 influenza virus for 24 h. Pure cytosolic extracts prepared from digitonin extracts of δNS1 influenza virus-infected cells were immunoprecipitated with mouse monoclonal antibody against Flag, followed by immunoblotting of immunoprecipitates with rabbit polyclonal antibody against Flag (left panel). DNA was extracted from immunoprecipitated samples using QIAquick Nucleotide Removal kit (QIAGEN). NS1-bound mtDNA was assessed by quantitative PCR (right panel). b HEK293FT cells were transfected with the expression plasmid encoding EGFP, Flag-tagged NS1, or NS1 38/41 mutant. Twenty-four hours after transfection, the cells were infected with δNS1 influenza virus for 24 h. Cell lysates were collected and blotted using the indicated antibodies (left panel). Cytosolic mtDNA was assessed by quantitative PCR (middle panel). IFN-β mRNA levels were assessed by quantitative PCR with β-actin as an internal control (right panel). c HEK293FT cells were infected with WT (rgPR8) or rgPR8/NS138/41A influenza virus at MOI of 1 for 24 h. Cell lysates were collected and blotted using the indicated antibodies (left panel). Cytosolic mtDNA (middle panel) and IFN-β mRNA levels (right panel) were assessed by quantitative PCR. d cGAS-293FT cells transfected with siRNA targeting STING or control siRNA were infected with rgPR8/NS138/41A influenza virus for 24 h. IFN-β mRNA levels were assessed by quantitative PCR with β-actin as an internal control. These data are from three independent experiments (mean ± s.e.m.). *P < 0.05, **P < 0.01, ***P < 0.001; (one-way ANOVA and Tukey’s test). Source data are provided as a Source Data file

false

Western blot - Anti-Influenza A Virus M2 Protein antibody [14C2] (AB5416)
  • WB

CiteAb

Western blot - Anti-Influenza A Virus M2 Protein antibody [14C2] (AB5416)

Western Blotting using Anti-Influenza A Virus M2 Protein antibody [14C2], ab5416. Publication image from Moriyama, M. et al., 2019, Nat Commun, 31604929. Legend direct from paper.

Influenza virus stimulates cGAS- and STING-dependent IFN-β gene expression in mouse lung fibroblast. a, b Primary lung fibroblast prepared from WT, cGAS-, STING-, and MAVS-deficient mice were infected with WT PR8 (a) or δNS1 influenza virus (b). IFN-β mRNA levels were assessed by quantitative PCR with GAPDH as an internal control. c Samples from HEK293FT cells stably expressing EGFP (EGFP-293FT) or cGAS (cGAS-293FT) were infected with PR8 or EMCV. Cell lysates were collected at 9 h post infection and blotted using the indicated antibodies. d EGFP-293FT or cGAS-293FT cells were infected with influenza virus (left panel) or EMCV (right panel) for 24 h. IFN-β mRNA levels were assessed by quantitative PCR with β-actin as an internal control. e, f STING-A549 cells (e) or lung fibroblasts (f) were infected with PR8 virus. Pure cytosolic extracts were collected at indicated time points and analyzed for cGAMP by ELISA. These data are from three independent experiments (a, b, d–f; mean ± s.e.m.). *P < 0.05, **P < 0.01, ***P < 0.001; (one-way ANOVA and Tukey’s test). Source data are provided as a Source Data file

false

Western blot - Anti-Influenza A Virus M2 Protein antibody [14C2] (AB5416)
  • WB

CiteAb

Western blot - Anti-Influenza A Virus M2 Protein antibody [14C2] (AB5416)

Western Blotting using Anti-Influenza A Virus M2 Protein antibody [14C2], ab5416. Publication image from Moriyama, M. et al., 2019, Nat Commun, 31604929. Legend direct from paper.

Ion channel activity of influenza virus M2 protein is essential for mtDNA release. a HEK293FT cells were transfected with the expression plasmid encoding EGFP or Flag-tagged influenza virus proteins. Cell lysates were collected at 24 h post transfection and analyzed by immunoblot with mouse monoclonal antibody against Flag or EGFP (left panel). Cytosolic mtDNA was assessed by quantitative PCR at 24 h post transfection (right panel). b HEK293FT cells were transfected with the expression plasmid encoding EGFP or Flag-tagged WT or mutant M2 protein. Cell lysates were collected at 24 h post transfection and analyzed by immunoblot using indicated antibodies (left panel). Cytosolic mtDNA was assessed by quantitative PCR at 24 h post transfection (right panel). c HEK293FT cells were transfected with the expression plasmid encoding EGFP or Flag-tagged M2 protein in the presence or absence of BAPTA-AM (20 µM) or Mito-TEMPO (500 µM). Cell lysates were collected at 24 h post transfection and blotted using the indicated antibodies (left panel). Cytosolic mtDNA was assessed by quantitative PCR at 24 h post transfection (right panel). d HEK293FT cells were transfected with siRNA targeting MAVS or control siRNA. Two days later, cells were transfected with the expression plasmid encoding EGFP or Flag-tagged M2 protein. Cell lysates were collected at 24 h post DNA transfection and blotted using the indicated antibodies (left panel). Cytosolic mtDNA was assessed by quantitative PCR at 24 h post DNA transfection (right panel). e, f HEK293FT cells were infected with WT (rgPR8), M2del29–31 virus (rgPR8/M2del29–31) (e), or amantadine sensitive-recombinant influenza virus (rgPR8/M2N31S) in the presence or absence of amantadine (100 µM) (f). Cytosolic mtDNA was assessed by quantitative PCR at 24 h post infection. These data are from three independent experiments (a–f; mean ± s.e.m.). ***P < 0.001; n.s., not significant (one-way ANOVA and Tukey’s test). Source data are provided as a Source Data file

false

Western blot - Anti-Influenza A Virus M2 Protein antibody [14C2] (AB5416)
  • WB

CiteAb

Western blot - Anti-Influenza A Virus M2 Protein antibody [14C2] (AB5416)

Western Blotting using Anti-Influenza A Virus M2 Protein antibody [14C2], ab5416. Publication image from Moriyama, M. et al., 2019, Nat Commun, 31604929. Legend direct from paper.

Connexin 43 amplifies influenza virus-induced STING-dependent innate immune signaling. a Schematic representation of experimental setup (left panel). cGAS-293FT cells were infected with δNS1 influenza virus (purple). Six hours later, uninfected WT (red) or STING KO (green) HEK293FT cells were added to the δNS1 influenza virus-infected cGAS-293FT cells (purple) and co-cultured for additional 18 h. IFN-β mRNA levels were assessed by quantitative PCR at 24 h post infection (right panel). b cGAS-293FT cells infected with δNS1 influenza virus in the presence or absence of CBX (160 µM). IFN-β mRNA levels were assessed by quantitative PCR at 24 h post infection. c cGAS-293FT cells were transfected with the expression plasmid encoding HA-tagged IRF3. Twenty-four hours after transfection, the cells were infected with δNS1 influenza virus in the presence or absence of CBX (160 µM). Cell lysates were collected at 12 h post infection and blotted using the indicated antibodies. d Samples from cGAS-293FT cells transfected with siRNA targeting connexin 43 (CX43) or control siRNA were blotted using the indicated antibodies (left panel) or intracellularly stained with CX43-specific antibody and analyzed by flow cytometry (right panel). e Schematic representation of experimental setup (left panel). cGAS-293FT cells transfected with siRNA targeting connexin 43 (CX43) or control siRNA were infected with δNS1 influenza virus (purple). Six hours later, uninfected HEK293FT cells (red) were added to the δNS1 influenza virus-infected cGAS-293FT cells (purple) and co-cultured for additional 18 h. IFN-β mRNA levels were assessed by quantitative PCR at 24 h post infection (right panel). These data are from three independent experiments (a, b, e; mean ± s.e.m.). *P < 0.05, **P < 0.01, ***P < 0.001; (one-way ANOVA and Tukey’s test). Source data are provided as a Source Data file

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

14C2

Isotype

IgG1

Light chain type

kappa

Carrier free

No

Reacts with

Influenza A

Applications

ICC

applications

Epitope

Detects the N-terminal of the Influenza A Virus M2 Protein.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICC" : {"fullname" : "Immunocytochemistry", "shortname":"ICC"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Influenza A": { "ICC-species-checked": "testedAndGuaranteed", "ICC-species-dilution-info": "1 µg/mL", "ICC-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Storage buffer
Preservative: 0.05% Sodium azide Constituents: PBS, 0.1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Influenza A Virus M2 Protein also known as M2 ion channel or matrix protein 2 plays an essential role in the viral life cycle. This protein has a mass of approximately 97 amino acids and is expressed on the envelope of the Influenza A virus. It functions as a proton-selective channel facilitating the acidification of the viral interior after the virus enters the host cell. This acidification process is important for the uncoating of the viral genome allowing subsequent replication of the virus in host cells.
Biological function summary

The M2 protein from Influenza A virus participates in virus assembly budding and release. The protein operates as a tetramer creating a channel across the viral membrane. This channel is essential for the correct function and structure of the virus playing an important role in membrane fusion and release of the viral particles. It often works in conjunction with another matrix protein M1 which assists in stabilizing the integrity of the viral structure.

Pathways

The M2 Influenza protein is integral to the viral replication and assembly pathway. It aligns with the function of the viral ribonucleoprotein complex and is significant in the viral entry and exit pathways. Additionally the connection to the M1 matrix protein highlights its coordinated role in facilitating the assembly and release of new virions from the infected cells emphasizing its necessity in productive viral replication.

The Influenza A virus M2 protein is directly related to the pathogenesis of seasonal influenza. Antiviral drugs like amantadine and rimantadine target this ion channel to disrupt viral replication. Resistance mutations in the M2 protein can influence the efficacy of these drugs impacting treatment outcomes. There is also a link with immune system responses where M2 interactions with other viral proteins can modulate host immune evasion mechanisms.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Publications (81)

Recent publications for all applications. Explore the full list and refine your search

Science advances 11:eadu7602 PubMed40498831

2025

Influenza A virus subverts the LC3-pericentrin dynein adaptor complex for host cytoplasm entry.

Applications

Unspecified application

Species

Unspecified reactive species

Yingying Cong,Pauline Verlhac,Benjamin B Green,Jacqueline de Vries-Idema,Line Moesgaard Strauss,Clàudia Río-Bergé,Anders Etzerodt,Lene N Nejsum,Anke L W Huckriede,Fulvio Reggiori

Viruses 16: PubMed39205283

2024

The M2 Protein of the Influenza A Virus Interacts with PEX19 to Facilitate Virus Replication by Disrupting the Function of Peroxisome.

Applications

Unspecified application

Species

Unspecified reactive species

Tanbin Liu,Libin Liang,Pu Zhao,Weipeng Lin,Yichao Zhuang,Li Jiang,Hualan Chen,Chengjun Li

Nature communications 15:6802 PubMed39122688

2024

Engineered probiotic Escherichia coli elicits immediate and long-term protection against influenza A virus in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Ling Huang,Wei Tang,Lina He,Mengke Li,Xian Lin,Ao Hu,Xindi Huang,Zhouyu Wu,Zhiyong Wu,Shiyun Chen,Yangbo Hu

Frontiers in microbiology 15:1423995 PubMed39035445

2024

Intracellular develops enhanced fluoroquinolone persistence during influenza A coinfection.

Applications

Unspecified application

Species

Unspecified reactive species

Mirelys Hernandez-Morfa,Nicolas M Reinoso-Vizcaino,Victoria E Zappia,Nadia B Olivero,Paulo R Cortes,Cinthia C Stempin,Daniel R Perez,Jose Echenique

JACC. Basic to translational science 7:1214-1228 PubMed36644282

2022

Targeting the Autophagy-Lysosome Pathway in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure.

Applications

Unspecified application

Species

Unspecified reactive species

Sarah Evans,Xiucui Ma,Xiqiang Wang,Yana Chen,Chen Zhao,Carla J Weinheimer,Attila Kovacs,Brian Finck,Abhinav Diwan,Douglas L Mann

The Journal of cell biology 221: PubMed36169638

2022

PI4P and BLOC-1 remodel endosomal membranes into tubules.

Applications

Unspecified application

Species

Unspecified reactive species

Riddhi Atul Jani,Aurélie Di Cicco,Tal Keren-Kaplan,Silvia Vale-Costa,Daniel Hamaoui,Ilse Hurbain,Feng-Ching Tsai,Mathilde Di Marco,Anne-Sophie Macé,Yueyao Zhu,Maria João Amorim,Patricia Bassereau,Juan S Bonifacino,Agathe Subtil,Michael S Marks,Daniel Lévy,Graça Raposo,Cédric Delevoye

Biophysical journal 120:5478-5490 PubMed34808098

2021

Influenza A M2 recruits M1 to the plasma membrane: A fluorescence fluctuation microscopy study.

Applications

Unspecified application

Species

Unspecified reactive species

Annett Petrich,Valentin Dunsing,Sara Bobone,Salvatore Chiantia

Cell reports 37:109899 PubMed34706226

2021

Subtractive CRISPR screen identifies the ATG16L1/vacuolar ATPase axis as required for non-canonical LC3 lipidation.

Applications

Unspecified application

Species

Unspecified reactive species

Rachel Ulferts,Elena Marcassa,Lewis Timimi,Liam Changwoo Lee,Andrew Daley,Beatriz Montaner,Suzanne Dawn Turner,Oliver Florey,John Kenneth Baillie,Rupert Beale

mBio 12:e0148421 PubMed34517760

2021

MARCH8 Restricts Influenza A Virus Infectivity but Does Not Downregulate Viral Glycoprotein Expression at the Surface of Infected Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Fernando Villalón-Letelier,Andrew G Brooks,Sarah L Londrigan,Patrick C Reading

Viruses 13: PubMed34578289

2021

Influenza Antigens NP and M2 Confer Cross Protection to BALB/c Mice against Lethal Challenge with H1N1, Pandemic H1N1 or H5N1 Influenza A Viruses.

Applications

Unspecified application

Species

Unspecified reactive species

Nutan Mytle,Sonja Leyrer,Jon R Inglefield,Andrea M Harris,Thomas E Hickey,Jacob Minang,Hang Lu,Zhidong Ma,Hanné Andersen,Nathan D Grubaugh,Tina Guina,Mario H Skiadopoulos,Michael J Lacy
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com